Ajax-Loading

Eli Lilly and Company - Ebit Interest Coverage

Eli Lilly and Company's Fiscal Year is From January To December.

The item "Ebit-Interest-Coverage" stands at 26.09 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Eli Lilly and Company's third quarter, the item "Ebit Interest Coverage" stands at 26.09. This represents an increase of 33.61 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 66.97 percent compared to the value the year prior.
The 1 year change in percent is 66.97.
The 3 year change in percent is 24.77.

The Serie's long term average value is 18.47. It's latest available value, on 09/30/2025, is 41.24 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +80.70%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Ebit Interest Coverage for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Ebit Interest Coverage486,508,953,600.00
LogoAbbVie Inc - Ebit Interest Coverage399,570,305,024.00
LogoRoche Holding AG - Ebit Interest Coverage317,433,206,677.55
LogoAstraZeneca PLC - Ebit Interest Coverage280,205,508,085.11
LogoNovartis AG - Ebit Interest Coverage255,096,620,580.91